CONMED | CNMD - Operating Profit



CONMED reported $65.71M in Operating Profit for its fiscal quarter ending in September of 2024.

Operating Profit Change Date
3M USD 1.32B 840M Sep/2024
Abbott USD 1.87B 37M Sep/2024
AtriCure USD -7405000 235K Sep/2024
Avanos Medical USD 12M 300K Sep/2024
Baxter International USD 155M 83M Sep/2024
Becton, Dickinson and Co. USD 650M 64M Sep/2024
Boston Scientific USD 718M 81M Sep/2024
CONMED USD 65.71M 27.3M Sep/2024
Cooper Companies USD 192.5M 30.8M Jul/2024
Dexcom USD 152M 6M Sep/2024
Edwards Lifesciences USD 394.3M 17.1M Sep/2024
Globus Medical USD 48.1M 16.03M Sep/2024
Hologic USD 230.1M 33.8M Sep/2024
Insulet USD 88.1M 33.5M Sep/2024
Integra LifeSciences USD -8150000 5.12M Sep/2024
Intuitive Surgical USD 577.3M 10M Sep/2024
J&J USD 5.32B 1.38B Sep/2024
Masimo USD 30.1M 1.8M Sep/2024
Medtronic USD 1.43B 224M Jun/2024
Merit Medical Systems USD 37.26M 8.99M Sep/2024
Olympus JPY 43.05B 15.44B Sep/2024
ResMed USD 387.31M 6.09M Sep/2024
Smith & Nephew USD 164M 14M Jun/2024
Steris USD 219.67M 4.74M Sep/2024
Stryker USD 1.08B 81M Sep/2024
Tandem Diabetes Care USD -26093000 4.68M Sep/2024
Teleflex USD 149.6M 24.87M Sep/2024
Zimmer Biomet Holdings USD 279.5M 71.8M Sep/2024